Salvage Therapy with Non-Heparinized Extracorporeal Life Support for Massive Lung Hemorrhage after Pulmonary Thromboembolectomy

Salvage Therapy with Non-Heparinized Extracorporeal Life Support for Massive Lung Hemorrhage after Pulmonary Thromboembolectomy Muneaki Matsubara, Yuji Hiramatsu*, Tomohiro Imazuru*, Masataka Sato, Chiho Tokunaga, Mio Noma*, Tomoaki Jikuya* and Yuzuru Sakakibara* (Department of Cardiovascular Surgery, Tsukuba University Hospital, Tsukuba, Japan and Department of Surgery, Institute of Clinical Medicine, University of Tsukuba*, Tsukuba, Japan) Lung hemorrhage associated with pulmonary reperfusion injury is a rare but lethal condition. We presented a case salvaged by non-heparinized extracorporeal life support for massive lung hemorrhage after pulmonary thromboembolectomy. Sub-acute pulmonary thromboembolism with a floating right atrial thrombus was diagnosed in 63-year-old woman by computed tomography and echocardiography. An emergency pulmonary thromboembolectomy was performed using cardiopulmonary bypass and moderate hypothermia. Immediately after reperfusion, extraordinary lung hemorrhage occurred and continued. We decided to take over the standard cardiopulmonary bypass with a non-heparinized extracorporeal life support system. Fortunately, hemostasis of the lung hemorrhage was completely secured within 12h, and the extracorporeal life support was terminated at 20h after the surgery. The patient was extubated at 48h after the surgery, and was discharged after the insertion of an inferior vena cava filter for a floating deep venous thrombus. Although the necessity, efficacy and risk of the non-heparinized extracorporeal life support should be clarified, we conclude that it could be the treatment of choice for life threatening lung hemorrhage associated with pulmonary reperfusion injury. Jpn. J. Cardiovasc. Surg. 33: 359-362 (2004)

[1]  T. Aiba,et al.  Appropriate indications for the use of a percutaneous cardiopulmonary support system in cases with cardiogenic shock complicating acute myocardial infarction. , 2001, Japanese circulation journal.

[2]  S. Takanashi,et al.  Acute pulmonary thromboembolism with a floating right-heart thrombus , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[3]  T. Kuriyama,et al.  Clinical characteristics of acute pulmonary thromboembolism in Japan: Results of a multicenter registry in the japanese society of pulmonary embolism research , 2001, Clinical cardiology.

[4]  A. Usui,et al.  Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials. , 1996, The Annals of thoracic surgery.

[5]  R. Colman,et al.  Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. , 1996, The Journal of thoracic and cardiovascular surgery.

[6]  L. Edmunds Why cardiopulmonary bypass makes patients sick: strategies to control the blood-synthetic surface interface. , 1995, Advances in cardiac surgery.

[7]  A. Usui,et al.  Nafamostat Mesilate Reduces Blood Loss During Open Heart Surgery , 1993, Circulation.

[8]  S. Brister,et al.  Thrombin Generation during Cardiac Surgery: Is Heparin the Ideal Anticoagulant? , 1993, Thrombosis and Haemostasis.

[9]  R. Tarazi,et al.  Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. , 1993, The Journal of thoracic and cardiovascular surgery.

[10]  K. Peterson,et al.  Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. , 1987, The Journal of thoracic and cardiovascular surgery.

[11]  K. Nolop,et al.  Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Association with lung neutrophil sequestration and tissue peroxidation. , 1986, The American review of respiratory disease.

[12]  R. Kikumoto,et al.  Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. , 1981, Biochemical and biophysical research communications.

[13]  B. Sproule,et al.  Hemorrhagic lung syndrome. Hemorrhagic lung infarction following pulmonary embolectomy. , 1973, The Annals of thoracic surgery.